Literature DB >> 28405744

Long-term follow-up of fellow eye in patients with lamellar macular hole.

Ugo Nava1, Matteo Giuseppe Cereda2, Ferdinando Bottoni2, Chiara Preziosa2, Marco Pellegrini2, Andrea Giani2, Giovanni Staurenghi2.   

Abstract

BACKGROUND: To evaluate macular changes in fellow eyes of patients diagnosed with lamellar macular hole (LMH) using spectral-domain optical coherence tomography (SD-OCT) and blue fundus autofluorescence (B-FAF).
METHODS: Fellow eyes of patients diagnosed with a LMH were retrospectively evaluated on OCT. Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) were recorded. Corresponding B-FAF images, vitreo-macular relations, and type of epiretinal membranes (ERMs) were also examined.
RESULTS: Thirty-five patients were included. At baseline, six fellow eyes (17%) showed a normal foveal profile, 26 (74%) had a tractional ERM, and three cases (9%) revealed a bilateral LMH, one of them with a lamellar hole-associated epiretinal proliferation (LHEP). A posterior vitreous detachment (PVD) was present in 29 patients (83%), four (11%) had only a vitreo-papillary adhesion (VPA), and two (6%) had both vitreo-macular adhesion (VMA) and VPA. After a mean follow-up of 4.6 ± 1.9 years, one eye (3%) developed a vitreous detachment from the macula with persistent VPA, and one developed a PVD from a VPA with subsequent ERM formation. BCVA and mean CFT remained stable in 35 eyes (100%). Likewise, no B-FAF signal variations were detected. One patient developed a LMH during the 3rd year of follow-up.
CONCLUSIONS: Our data suggest that the presence of a LMH in one eye does not increase significantly the risk of developing the same condition in the fellow eye after 4 years. Bilateral condition is uncommon, and an ERM is often detected in the fellow eye. LHEPs were not observed in fellow eyes with foveal integrity, and all LHEPs observed (in main and fellow eyes) were always associated with LMHs; this supports the hypothesis that LHEP is a consequence and not a causative factor for LMHs. The occurrence of a LMH in one fellow eye after 3 years follow-up may suggest that a higher incidence of bilateral disease could develop in a longer time span.

Entities:  

Keywords:  Epiretinal membrane; Epiretinal proliferation; Lamellar macular hole; Lamellar macular hole fellow eye; Vitreoretinal interface

Mesh:

Year:  2017        PMID: 28405744     DOI: 10.1007/s00417-017-3652-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Diagnosis of macular pseudoholes and lamellar macular holes by optical coherence tomography.

Authors:  Belkacem Haouchine; Pascale Massin; Ramin Tadayoni; Ali Erginay; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2004-11       Impact factor: 5.258

2.  Diagnosis of macular pseudoholes and lamellar macular holes: is optical coherence tomography the "gold standard"?

Authors:  F Bottoni; L Carmassi; M Cigada; S Moschini; F Bergamini
Journal:  Br J Ophthalmol       Date:  2008-02-01       Impact factor: 4.638

Review 3.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

4.  Lamellar Hole-Associated Epiretinal Proliferation in Comparison to Epiretinal Membranes of Macular Pseudoholes.

Authors:  Denise Compera; Enrico Entchev; Christos Haritoglou; Renate Scheler; Wolfgang J Mayer; Armin Wolf; Anselm Kampik; Ricarda G Schumann
Journal:  Am J Ophthalmol       Date:  2015-05-15       Impact factor: 5.258

5.  [The vitreoretinal interface and its role in the pathogenesis of vitreomaculopathies].

Authors:  J Sebag
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

6.  Anatomic and visual outcomes of vitrectomy for lamellar macular holes.

Authors:  Andre J Witkin; Leonardo C Castro; Elias Reichel; Adam H Rogers; Caroline R Baumal; Jay S Duker
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010 Jul-Aug

7.  The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study.

Authors:  Stacy M Meuer; Chelsea E Myers; Barbara E K Klein; Maria K Swift; Yijun Huang; Sapna Gangaputra; Jeong W Pak; Ronald P Danis; Ronald Klein
Journal:  Ophthalmology       Date:  2014-12-31       Impact factor: 12.079

8.  Lamellar macular hole: a complication of cystoid macular edema after cataract extraction.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1976-05

9.  Contraction of a perifoveal epiretinal membrane simulating a macular hole.

Authors:  A W Allen; J D Gass
Journal:  Am J Ophthalmol       Date:  1976-11       Impact factor: 5.258

10.  The natural history of lamellar macular holes: a spectral domain optical coherence tomography study.

Authors:  Ferdinando Bottoni; Antonio Peroglio Deiro; Andrea Giani; Claudia Orini; Mario Cigada; Giovanni Staurenghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-09       Impact factor: 3.117

View more
  4 in total

Review 1.  Surgical interventions for lamellar macular holes.

Authors:  Declan C Murphy; Jon Rees; David Hw Steel
Journal:  Cochrane Database Syst Rev       Date:  2021-11-08

2.  Outcomes from the Retrospective Multicenter Cross-Sectional Study on Lamellar Macular Hole Surgery.

Authors:  Hanna Haave; Beáta Éva Petrovski; Zofia Anna Nawrocka; Goran Petrovski; Michał Zając; Xhevat Lumi; Wassiliki Melekidou; Lyubomyr Lytvynchuk; Andrii Ruban; Ljubo Znaor; Jerzy Nawrocki
Journal:  Clin Ophthalmol       Date:  2022-06-08

Review 3.  Primary Lamellar Macular Holes: To Vit or Not to Vit.

Authors:  Lihteh Wu; Ryan Bradshaw
Journal:  J Clin Med       Date:  2022-08-28       Impact factor: 4.964

4.  A multifocal electroretinography study to evaluate risk of developing macular hole in the fellow eye of patients suffering with unilateral macular hole.

Authors:  Daleena Dalan; Durgasri Jaisankar; Karthiga Mani; Abinaya Madhu; Dhanashree Ratra
Journal:  Ther Adv Ophthalmol       Date:  2020-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.